Are you Dr. Pergolizzi?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 48 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
868 106th Ave N
Naples, FL 34108Phone+1 239-597-3564Fax+1 239-908-4436
Summary
- Dr. Joseph Pergolizzi Jr., MD is an anesthesiologist in Naples, Florida. He is currently licensed to practice medicine in Florida.
Education & Training
- MedStar Health/Georgetown University HospitalResidency, Anesthesiology, 1997 - 2000
- Greater Baltimore Medical CenterInternship, Internal Medicine, 1996 - 1997
- Ross University School of MedicineClass of 1996
Certifications & Licensure
- FL State Medical License 2000 - 2026
Clinical Trials
- Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Diabetic Peripheral Neuropathy Start of enrollment: 2006 Sep 01
- Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Chemotherapy-Induced Neuropathy Start of enrollment: 2006 Oct 01
- Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Multiple Sclerosis Start of enrollment: 2006 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 13 citationsThe Role of Lofexidine in Management of Opioid Withdrawal.Joseph V. Pergolizzi, Hani Annabi, Christopher Gharibo, Jo Ann LeQuang
Pain and Therapy. 2019-06-01 - 122 citationsManagement of Musculoskeletal Pain: An Update with Emphasis on Chronic Musculoskeletal PainSalah N. El-Tallawy, Rohit Nalamasu, Gehan I. Salem, Jo Ann LeQuang, Joseph V. Pergolizzi
Pain and Therapy. 2021-02-11 - 216 citationsCurrent knowledge of buprenorphine and its unique pharmacological profile.Joseph V. Pergolizzi, Anna Maria Aloisi, Albert Dahan, Joerg Filitz, Richard M. Langford
Pain Practice. 2010-09-01
Press Mentions
- Nuance Pharma Announces the Completion of Dosing for All NTM-001 Phase 1 Clinical Study Participants in HKU Clinical Trials CentreJuly 26th, 2022
- Atrial Fibrilillation Study by NativeCardio and the Texas Heart Institute Show Ultra-Low Cardioversion Is PossibleJanuary 24th, 2022
- Neumentum to Participate in the UBS Biotechnology Private Company SymposiumSeptember 15th, 2021
- Join now to see all